Cargando…

The Emerging Role of GLP-1 Receptors in DNA Repair: Implications in Neurological Disorders

Glucagon-like peptide-1 (GLP-1) is originally found as a metabolic hormone (incretin) that is able to regulate blood-glucose levels via promoting synthesis and secretion of insulin. GLP-1 and many analogues are approved for treatment of type II diabetes. Accumulating results imply that GLP-1 perform...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Jenq-Lin, Chen, Wei-Yu, Chen, Shang-Der
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618510/ https://www.ncbi.nlm.nih.gov/pubmed/28846606 http://dx.doi.org/10.3390/ijms18091861

Ejemplares similares

Activation of GLP-1 Receptor Enhances Neuronal Base Excision Repair via PI3K-AKT-Induced Expression of Apurinic/Apyrimidinic Endonuclease 1
por: Yang, Jenq-Lin, et al.
Publicado: (2016)

Emerging Roles of Sonic Hedgehog in Adult Neurological Diseases: Neurogenesis and Beyond
por: Chen, Shang-Der, et al.
Publicado: (2018)

Effects of GLP-1 receptor agonists on neurological complications of diabetes
por: García-Casares, Natalia, et al.
Publicado: (2023)

Emerging role of GLP-1 receptor agonists in the treatment of obesity
por: Neff, Lisa M, et al.
Publicado: (2010)

Emerging Roles of Sestrins in Neurodegenerative Diseases: Counteracting Oxidative Stress and Beyond
por: Chen, Shang-Der, et al.
Publicado: (2019)

Brain GLP‐1 and the regulation of food intake: GLP‐1 action in the brain and its implications for GLP‐1 receptor agonists in obesity treatment
por: Trapp, Stefan, et al.
Publicado: (2021)

IGF-1 and GLP-1 signaling: potential therapeutic target for neurological disorders – correspondence
por: Gajwani, Neeraj, et al.
Publicado: (2023)

Emerging Roles of Inhibitor of Differentiation-1 in Alzheimer’s Disease: Cell Cycle Reentry and Beyond
por: Chen, Shang-Der, et al.
Publicado: (2020)

Emerging Role of Caveolin-1 in GLP-1 Action
por: Puddu, Alessandra, et al.
Publicado: (2021)

Glucagon‐like peptide‐1 (GLP‐1) receptor agonists and their cardiovascular benefits—The role of the GLP‐1 receptor
por: Helmstädter, Johanna, et al.
Publicado: (2021)

Impact of gut–brain interaction in emerging neurological disorders
por: Lin, Muh-Shi, et al.
Publicado: (2023)

Emerging Roles of IL-33/ST2 Axis in Renal Diseases
por: Chen, Wei-Yu, et al.
Publicado: (2017)

The emerging role of RNAs in DNA damage repair
por: Hawley, Ben R, et al.
Publicado: (2017)

Diverse roles of mitochondria in ischemic stroke
por: Yang, Jenq-Lin, et al.
Publicado: (2018)

Emerging Nondopaminergic Medications for Parkinson’s Disease: Focusing on A(2A) Receptor Antagonists and GLP1 Receptor Agonists
por: Shang, Pei, et al.
Publicado: (2021)

The Emerging Role of the Interaction of Extracellular Vesicle and Autophagy—Novel Insights into Neurological Disorders
por: Wei, Wei, et al.
Publicado: (2022)

Role of Metabotropic Glutamate Receptors in Neurological Disorders
por: Crupi, Rosalia, et al.
Publicado: (2019)

Emerging therapeutic role of gut microbial extracellular vesicles in neurological disorders
por: Sun, Bowen, et al.
Publicado: (2023)

GLP−1 receptor agonists for the treatment of obesity: Role as a promising approach
por: Wang, Jing-Yue, et al.
Publicado: (2023)

The emerging role of minor intron splicing in neurological disorders
por: Jutzi, Daniel, et al.
Publicado: (2018)

Emerging Role of m(6) A Methylome in Brain Development: Implications for Neurological Disorders and Potential Treatment
por: Sokpor, Godwin, et al.
Publicado: (2021)

Polymorphisms of GLP-1 Receptor Gene and Response to GLP-1 Analogue in Patients with Poorly Controlled Type 2 Diabetes
por: Lin, Chia-Hung, et al.
Publicado: (2015)

The Emerging Role of Dual GLP-1 and GIP Receptor Agonists in Glycemic Management and Cardiovascular Risk Reduction
por: Rizvi, Ali A, et al.
Publicado: (2022)

GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential
por: Ma, Xiaoxuan, et al.
Publicado: (2021)

Bone-Derived Modulators That Regulate Brain Function: Emerging Therapeutic Targets for Neurological Disorders
por: Chen, Hongzhen, et al.
Publicado: (2021)

Novel GLP-1 Fusion Chimera as Potent Long Acting GLP-1 Receptor Agonist
por: Wang, Qinghua, et al.
Publicado: (2010)

Role and development of GLP-1 receptor agonists in the management of diabetes
por: Chia, Chee W, et al.
Publicado: (2009)

New Insights into and Emerging Roles of Animal Models for Neurological Disorders
por: Moon, Changjong
Publicado: (2022)

Emerging Role of Neuron-Glia in Neurological Disorders: At a Glance
por: Rahman, Md. Mominur, et al.
Publicado: (2022)

Emerging Role of MicroRNA-30c in Neurological Disorders
por: Kumar, Manish, et al.
Publicado: (2022)

Novel agonist and antagonist radioligands for the GLP‐2 receptor. Useful tools for studies of basic GLP‐2 receptor pharmacology
por: Gadgaard, Sarina, et al.
Publicado: (2022)

Purslane Effect on GLP-1 and GLP-1 receptor in type 2 diabetes
por: Heidarzadeh, Sara, et al.
Publicado: (2013)

Implications of Withaferin A in neurological disorders
por: Ram, Natasha, et al.
Publicado: (2020)

Implications of COVID-19 in Neurological Disorders
por: Gaddam, Satish
Publicado: (2020)

The Role of the Gastrointestinal Mucus System in Intestinal Homeostasis: Implications for Neurological Disorders
por: Herath, Madushani, et al.
Publicado: (2020)

The role of selenoproteins in neurodevelopment and neurological function: Implications in autism spectrum disorder
por: Behl, Supriya, et al.
Publicado: (2023)

Sigma receptors and neurological disorders
por: Piechal, Agnieszka, et al.
Publicado: (2021)

Emerging Roles for Long Non-Coding RNAs in Cancer and Neurological Disorders
por: Niland, Courtney N., et al.
Publicado: (2012)

An Emerging Role for Long Non-Coding RNA Dysregulation in Neurological Disorders
por: Fenoglio, Chiara, et al.
Publicado: (2013)

The role of Cdk5 in neurological disorders
por: Ao, Chuncao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s4sk5frrs8uflkakk93l5sv8vi